| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir
|
Huang, Pao-Yuan
|
|
|
15 |
2 |
p. 310-317
|
article
|
| 2 |
Author’s reply to “Thromboelastometry in patients with advanced chronic liver disease: a complex interplay”
|
Raeven, Pierre
|
|
|
15 |
2 |
p. 522-524
|
article
|
| 3 |
Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients
|
Biewenga, Maaike
|
|
|
15 |
2 |
p. 510-519
|
article
|
| 4 |
Chronic hepatitis B: the demise of the ‘inactive carrier’ phase
|
Koffas, Apostolos
|
|
|
15 |
2 |
p. 290-300
|
article
|
| 5 |
Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma
|
Huang, Shang-Chin
|
|
|
15 |
2 |
p. 472-481
|
article
|
| 6 |
Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessation
|
Kuo, Yuan-Hung
|
|
|
15 |
2 |
p. 301-309
|
article
|
| 7 |
Correction to: Targeting the ileal bile salt transporter in the treatment of non‑alcoholic fatty liver disease
|
Jansen, Peter L. M.
|
|
|
15 |
2 |
p. 529
|
article
|
| 8 |
C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3
|
Lin, Jiong
|
|
|
15 |
2 |
p. 526
|
article
|
| 9 |
Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter study
|
Liang, Lei
|
|
|
15 |
2 |
p. 459-471
|
article
|
| 10 |
Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?
|
Guerreiro, Gabriel Tayguara Silveira
|
|
|
15 |
2 |
p. 380-391
|
article
|
| 11 |
Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines
|
Devarbhavi, Harshad
|
|
|
15 |
2 |
p. 258-282
|
article
|
| 12 |
Dual targeting of PD-L1 and PD-L2 by PCED1B-AS1 via sponging hsa-miR-194-5p induces immunosuppression in hepatocellular carcinoma
|
Fan, Fei
|
|
|
15 |
2 |
p. 444-458
|
article
|
| 13 |
Dynamic Optic Nerve Sheath Diameter (ONSD) guided management of raised intracranial pressure in pediatric acute liver failure
|
Vijay, Priti
|
|
|
15 |
2 |
p. 502-509
|
article
|
| 14 |
Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice
|
Yamauchi, Ryo
|
|
|
15 |
2 |
p. 392-404
|
article
|
| 15 |
Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease
|
Xu, Yu
|
|
|
15 |
2 |
p. 350-365
|
article
|
| 16 |
High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B
|
Duan, Menghui
|
|
|
15 |
2 |
p. 318-327
|
article
|
| 17 |
Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease
|
Jin, Jing-Lu
|
|
|
15 |
2 |
p. 413-423
|
article
|
| 18 |
Liver injury predicts overall mortality in severe COVID-19: a prospective multicenter study in Brazil
|
Pozzobon, Fernanda Manhães
|
|
|
15 |
2 |
p. 493-501
|
article
|
| 19 |
Neonatal hepatitis B vaccination protects mature adults from occult virus infection
|
Wang, Ruijun
|
|
|
15 |
2 |
p. 328-337
|
article
|
| 20 |
Paris II and Rotterdam criteria are the best predictors of outcomes in patients with primary biliary cholangitis in Japan
|
Kimura, Naruhiro
|
|
|
15 |
2 |
p. 437-443
|
article
|
| 21 |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu, Chen-Hua
|
|
|
15 |
2 |
p. 338-349
|
article
|
| 22 |
Targeting the ileal bile salt transporter in the treatment of non-alcoholic fatty liver disease
|
Jansen, Peter L. M.
|
|
|
15 |
2 |
p. 283-286
|
article
|
| 23 |
The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis
|
Wang, Guiqiang
|
|
|
15 |
2 |
p. 223-257
|
article
|
| 24 |
The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040
|
Ito, Takanori
|
|
|
15 |
2 |
p. 366-379
|
article
|
| 25 |
The longitudinal outcomes of applying non-selective beta-blockers in portal hypertension: real-world multicenter study
|
Kang, Seong Hee
|
|
|
15 |
2 |
p. 424-436
|
article
|
| 26 |
The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients
|
Peng, Chien-Wei
|
|
|
15 |
2 |
p. 527-528
|
article
|
| 27 |
The metabolic profiles and body composition of lean metabolic associated fatty liver disease
|
Cheng, Yu-Ming
|
|
|
15 |
2 |
p. 405-412
|
article
|
| 28 |
The prevalence of occult HBV infection in immunized children with HBs Ag positive parents: a hospital based analysis
|
Patil, Srinith B.
|
|
|
15 |
2 |
p. 525
|
article
|
| 29 |
Thromboelastometry in patients with advanced chronic liver disease: a complex interplay
|
Sharma, Sanchit
|
|
|
15 |
2 |
p. 520-521
|
article
|
| 30 |
Toward a new landscape for the mechanism of immunosuppression in hepatocellular carcinoma
|
Su, Chien-Wei
|
|
|
15 |
2 |
p. 287-289
|
article
|
| 31 |
Weight fluctuation and risk of hepatocellular carcinoma: a nationwide population-based 8-million-subject study
|
Chang, Young
|
|
|
15 |
2 |
p. 482-492
|
article
|
Journal description